CLOV vs NAGE · rev $1.37B vs P/E 59, rev $99.6M
Clover Health Investments Corp (CLOV) versus Niagen Bioscience, Inc. (NAGE) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported NAGE revenue for 2024-12-31 was $99.6M. Net income was $8.6M. Revenue was up 19.2% from 2023-12-31 to 2024-12-31. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
CLOV currently screens at market cap $1.55B. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Not investment advice. Open the CLOV and NAGE stock pages for the full models.
Not investment advice.